表紙
市場調查報告書

全球人工器官市場

Artificial Organs

出版商 Global Industry Analysts, Inc. 商品編碼 236739
出版日期 內容資訊 英文 135 Pages
商品交期: 最快1-2個工作天內
價格
全球人工器官市場 Artificial Organs
出版日期: 2020年09月01日內容資訊: 英文 135 Pages
簡介

本報告包括全球人工器官市場的調查、產業概要、個別階段市場分析、市場動向與課題、影響市場的因素、技術動向、產品概要、規格環境、與主要企業基本資料等整合報告。

第1章 介紹、調查方法、產品定義

第2章 產業概要

  • 醫療技術業界因為人工器官而引起的革命
  • 帶動成長的因素
  • 不利成長的因素
  • 人工器官的需求
  • 美國:獨佔人工器官市場的勢力
  • 人工器官市場中最大的比率來自人工腎臟
  • 需求與供應失衡
  • 競爭激烈
  • 技術進步促進成長

第3章 個別市場分析

  • 人工心臟
  • 人工腎臟
  • 人工肝臟
  • 人工胰臟

第4章 市場動向與課題

  • 心血管疾病的發作率增加促成了人工心臟□VAD市場的成長
  • 開發成本高□長期的監管程序
  • 必要性的專門知識不足
  • 異種移植 - 器官捐贈者不足的情況下的另一個選擇
  • 經由克隆動物細胞而製造的人工器官 - 有希望的方向
  • 在人工器官市場上被期待的免疫抑製藥劑
  • 小型移植裝置的動向
  • 加入市場的極大阻礙是透析設備、其他

第5章 人工器官市場的宏觀影響因素

  • 人口高齡化:是重要的促進成長因素
  • 全球人口高齡化統計 - 機會指標
  • ESRD□CKD患者人口增加 - 促進腎臟透析治療的主要因素
  • 罹患腎臟疾病的比率上升造成透析市場正在穩定的成長中
  • 透析患者的分佈:按照形式分別
  • 先進市場維持領先地位、新興市場的追趕
  • 糖尿病發生比率增加:人工胰臟的機會指標
  • 在孩童身上I型糖尿病症例數字的增加

第6章 3D生物列印技術

  • 在醫療業界中3D生物列印技術的用途
  • 在醫療業界中人工器官開發版塊引起革命的3D生物列印技術
  • 「柔軟的」3D生物列印技術解決了以塑膠為主的人工器官的印象
  • 可配合掃瞄達成的實時回報技術用在3D列印器官上

第7章 技術進步

  • UCLA的研究者們開發出與癌對抗的細胞、其他

第8章 產品概要

第9章 規格環境

  • 美國的規格環境
  • 歐洲的規格環境

第10章 競爭情況

  • 受矚目的主要企業
    • ABBOTT (美國)
    • Abiomed, Inc. (美國)
    • Asahi Kasei Medical (日本)
    • Baxter International, Inc. (美國)
    • F.Hoffmann-La Roche Ltd. (瑞士)
    • Fresenius Medical Care AG & Co. KGaA (德國)
    • Jarvik Heart, Inc. (美國)
    • Medtronic, Inc. (美國)
    • HeartWare International, Inc. (美國)
    • NIKKISO CO., LTD. (日本)
    • NIPRO CORPORATION (日本)
    • SynCardia Systems, LLC (美國)
    • Toray Medical Co.,Ltd. (日本)
    • Xenios AG (德國)
  • 近年的產業活動

第11章 全球市場之展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1126

Global Artificial Organs Market to Reach $27.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Artificial Organs estimated at US$17.5 Billion in the year 2020, is projected to reach a revised size of US$27.4 Billion by 2027, growing at a CAGR of 6.6% over the analysis period 2020-2027. Artificial Kidneys, one of the segments analyzed in the report, is projected to record a 7.3% CAGR and reach US$14.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Artificial Pancreas segment is readjusted to a revised 6.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $5.2 Billion, While China is Forecast to Grow at 6.2% CAGR

The Artificial Organs market in the U.S. is estimated at US$5.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2027 trailing a CAGR of 6.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.3% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Artificial Liver Segment to Record 5.5% CAGR

In the global Artificial Liver segment, USA, Canada, Japan, China and Europe will drive the 5.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.4 Billion in the year 2020 will reach a projected size of US$3.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.1 Billion by the year 2027.We bring years of research experience to this 16th edition of our report. The 135-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories
  • Abiomed Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter International Inc.
  • F.Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • HeartWare International Inc.
  • Jarvik Heart Inc.
  • Medtronic Inc.
  • Nikkiso Co. Ltd.
  • Nipro Corp.
  • SynCardia Systems LLC
  • Toray Medical Co., Ltd.
  • Xenios AG

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Recent Market Activity
    • Artificial Organs Revolutionize Medical Industry
    • Growth Drivers
    • Growth Inhibitors
    • Artificial Organs Poised to Witness Significant Demand
    • The United States - A Dominant Force in the Artificial Organs Market
    • Artificial Kidneys Garner a Larger Pie in the Artificial Organs Market
    • Demand and Supply Imbalance
    • Competitive Scenario
    • Technological Advancements Spearheading Growth
    • Global Competitor Market Shares
    • Artificial Organs Competitor Market Share Scenario Worldwide (in %): 2020 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • ABBOTT (USA)
    • Abiomed, Inc. (USA)
    • Asahi Kasei Medical Co., Ltd. (Japan)
    • Baxter International, Inc. (USA)
    • F.Hoffmann-La Roche Ltd. (Switzerland)
    • Fresenius Medical Care AG & Co. KGaA (Germany)
    • Jarvik Heart, Inc. (USA)
    • Medtronic, Inc. (USA)
    • HeartWare International, Inc. (USA)
    • Nikkiso Co., Ltd. (Japan)
    • Nipro Corporation (Japan)
    • SynCardia Systems, LLC (USA)
    • Toray Medical Co., Ltd. (Japan)
    • Xenios AG (Germany)
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Cardiovascular Disease Drive the Market for Artificial Heart and VAD
    • Higher Development Costs and Lengthy Regulatory Process - Stumbling Blocks for Product Commercialization
    • Lack of Requisite Expertise - Hindering Implantation Process
    • Xenotransplantation - Other Alternative to Donor Organ Shortage
    • Artificial Organs from Cloned Animal Cells - A Promising Trend
    • Immunosuppressants Hold Promise in Artificial Organs Market
    • Move towards Smaller Implantable Devices
    • Barriers to Entry Significantly High in Dialyzers Market
    • Reuse of Dialyzers - A Major Issue in Dialysis Industry
    • Poor Reimbursement Environment Stymies Innovation
    • Product Recalls - A Major Blow to the Manufacturers
    • Higher Cost of Artificial Organs Hampers Broader Adoption
    • Major Issues Related to Artificial Organs
    • Financial
    • Legal
    • Ethical
    • Social
    • UCLA Researchers Develop Cancer-Fighting Cells
    • Production of 3D-like Artificial Organs in a Device that Works like a Cotton Candy Machine
    • Harvard Scientists Create Tissue Containing Blood Vessels
    • University of Washington Researchers Create Communicating Yeast Cells
    • Scientists Define Morphospace to Evaluate Viability of Artificial Organs
    • Application of 3D-Printing in the Medical Field
    • 3D Printing Revolutionizing the Medical Industry's Artificial Organ Development Segment
    • "Soft" 3D Bioprinting Eliminates Concerns of Hard Plastic-based Organ Models
    • 3D Printed Organ Models with Sensors Enable Real-time Feedback
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Artificial Organs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 2: Artificial Organs Global Retrospective Market Scenario in US$ Million by Region/Country: 2012
    • TABLE 3: Artificial Organs Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS
    • TABLE 4: Artificial Kidneys (Segment) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 5: Artificial Kidneys (Segment) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 6: Artificial Kidneys (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 7: Artificial Pancreas (Segment) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 8: Artificial Pancreas (Segment) Historic Market Perspective by Region/Country in US$ Million: 2012 to
    • TABLE 9: Artificial Pancreas (Segment) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 10: Artificial Liver (Segment) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 11: Artificial Liver (Segment) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to
    • TABLE 12: Artificial Liver (Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 13: Artificial Heart (Segment) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to
    • TABLE 14: Artificial Heart (Segment) Market Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 15: Artificial Heart (Segment) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 16: Artificial Lungs (Segment) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 17: Artificial Lungs (Segment) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 18: Artificial Lungs (Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Artificial Organs Market Share (in %) by Company: 2020 &
    • Market Analytics
    • TABLE 19: United States Artificial Organs Market Estimates and Projections in US$ Million by Segment: 2020 to
    • TABLE 20: Artificial Organs Market in the United States by Segment: A Historic Review in US$ Million for 2012
    • TABLE 21: United States Artificial Organs Market Share Breakdown by Segment: 2012 VS 2020 VS
  • CANADA
    • TABLE 22: Canadian Artificial Organs Market Estimates and Forecasts in US$ Million by Segment: 2020 to
    • TABLE 23: Canadian Artificial Organs Historic Market Review by Segment in US$ Million: 2012
    • TABLE 24: Artificial Organs Market in Canada: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and
  • JAPAN
    • TABLE 25: Japanese Market for Artificial Organs: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2020
    • TABLE 26: Artificial Organs Market in Japan: Historic Sales Analysis in US$ Million by Segment for the Period 2012
    • TABLE 27: Japanese Artificial Organs Market Share Analysis by Segment: 2012 VS 2020 VS
  • CHINA
    • TABLE 28: Chinese Artificial Organs Market Growth Prospects in US$ Million by Segment for the Period 2020
    • TABLE 29: Artificial Organs Historic Market Analysis in China in US$ Million by Segment: 2012
    • TABLE 30: Chinese Artificial Organs Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and
  • EUROPE
    • Market Facts & Figures
    • European Artificial Organs Market: Competitor Market Share Scenario (in %) for 2020 &
    • Market Analytics
    • TABLE 31: European Artificial Organs Market Demand Scenario in US$ Million by Region/Country: 2020
    • TABLE 32: Artificial Organs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012
    • TABLE 33: European Artificial Organs Market Share Shift by Region/Country: 2012 VS 2020 VS
    • TABLE 34: European Artificial Organs Market Estimates and Forecasts in US$ Million by Segment: 2020
    • TABLE 35: Artificial Organs Market in Europe in US$ Million by Segment: A Historic Review for the Period 2012
    • TABLE 36: European Artificial Organs Market Share Breakdown by Segment: 2012 VS 2020 VS
  • FRANCE
    • TABLE 37: Artificial Organs Market in France by Segment: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 38: French Artificial Organs Historic Market Scenario in US$ Million by Segment: 2012
    • TABLE 39: French Artificial Organs Market Share Analysis by Segment: 2012 VS 2020 VS
  • GERMANY
    • TABLE 40: Artificial Organs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2020
    • TABLE 41: German Artificial Organs Historic Market Analysis in US$ Million by Segment: 2012
    • TABLE 42: German Artificial Organs Market Share Breakdown by Segment: 2012 VS 2020 VS
  • ITALY
    • TABLE 43: Italian Artificial Organs Market Growth Prospects in US$ Million by Segment for the Period 2020
    • TABLE 44: Artificial Organs Historic Market Analysis in Italy in US$ Million by Segment: 2012
    • TABLE 45: Italian Artificial Organs Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and
  • UNITED KINGDOM
    • TABLE 46: United Kingdom Market for Artificial Organs: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2020
    • TABLE 47: Artificial Organs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Segment for the Period 2012
    • TABLE 48: United Kingdom Artificial Organs Market Share Analysis by Segment: 2012 VS 2020 VS
  • REST OF EUROPE
    • TABLE 49: Rest of Europe Artificial Organs Market Estimates and Forecasts in US$ Million by Segment: 2020
    • TABLE 50: Artificial Organs Market in Rest of Europe in US$ Million by Segment: A Historic Review for the Period 2012
    • TABLE 51: Rest of Europe Artificial Organs Market Share Breakdown by Segment: 2012 VS 2020 VS
  • ASIA-PACIFIC
    • TABLE 52: Artificial Organs Market in Asia-Pacific by Segment: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 53: Asia-Pacific Artificial Organs Historic Market Scenario in US$ Million by Segment: 2012
    • TABLE 54: Asia-Pacific Artificial Organs Market Share Analysis by Segment: 2012 VS 2020 VS
  • REST OF WORLD
    • TABLE 55: Rest of World Artificial Organs Market Estimates and Forecasts in US$ Million by Segment: 2020 to
    • TABLE 56: Rest of World Artificial Organs Historic Market Review by Segment in US$ Million: 2012
    • TABLE 57: Artificial Organs Market in Rest of World: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and

IV. COMPETITION

  • Total Companies Profiled: 42